Thrombopoietin mimetics vs placebo
All adverse events · Adult patients with myelodysplastic syndromes and thrombocytopenia
Thrombopoietin mimetics showed no clear difference in all adverse events compared with placebo (moderate certainty).
1 finding from 1 review
- Thrombopoietin mimetics for patients with myelodysplastic syndromes 2017 · Cochrane Headline outcomes onlyRR 1.01 [0.96, 1.07]5 studies · 390 participantsModerate